ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 4th, 2024 • Nektar Therapeutics • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of the 1st day of November, 2024, by and between Nektar Therapeutics, a Delaware corporation (“Seller”), and [* * *], a Delaware corporation (“Purchaser”). Seller and Purchaser are each individually referred to herein as a “Party” and collectively, as the “Parties”.
